- Home
- NBIX vs HMY Comparison
NBIX vs HMY Comparison
Compare NBIX & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBIX | HMY |
|---|---|---|
| Founded | 1992 | 1950 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.4B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | NBIX | HMY |
|---|---|---|
| Price | $142.31 | $20.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $176.19 | $16.00 |
| AVG Volume (30 Days) | 977.3K | ★ 3.8M |
| Earning Date | 02-05-2026 | 02-04-2016 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | 12.44 | ★ 67.74 |
| EPS | ★ 4.19 | 1.29 |
| Revenue | $2,682,700,000.00 | ★ $4,161,584,110.00 |
| Revenue This Year | $23.76 | $39.51 |
| Revenue Next Year | $18.01 | $14.06 |
| P/E Ratio | $33.80 | ★ $15.78 |
| Revenue Growth | 19.61 | ★ 20.39 |
| 52 Week Low | $84.23 | $7.97 |
| 52 Week High | $160.18 | $22.25 |
Technical Indicators
Market Signals| Indicator | NBIX | HMY |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 60.53 |
| Support Level | $151.09 | $19.71 |
| Resistance Level | $155.55 | $20.80 |
| Average True Range (ATR) | 4.52 | 0.81 |
| MACD | -1.41 | 0.08 |
| Stochastic Oscillator | 5.75 | 60.58 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.